MMP9 and gastric cancer: In an additional proof-of-principle approach, we measured the expression of MMP2, MMP7 and MMP9 in MKN45 gastric cancer cells before and after treatment with the mTOR inhibitor rapamycin to investigate the putative link between mTOR signalling and MMP expression in gastric cancer.